Logo image of OPRA

OPERA LTD-ADR (OPRA) Stock Fundamental Analysis

USA - NASDAQ:OPRA - US68373M1071 - ADR

19.62 USD
+0.21 (+1.08%)
Last: 9/18/2025, 6:59:53 PM
19.74 USD
+0.12 (+0.61%)
After Hours: 9/18/2025, 6:59:53 PM
Fundamental Rating

7

OPRA gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 280 industry peers in the Software industry. OPRA is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. An interesting combination arises when we look at growth and value: OPRA is growing strongly while it also seems undervalued. These ratings could make OPRA a good candidate for value and growth investing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

OPRA had positive earnings in the past year.
OPRA had a positive operating cash flow in the past year.
OPRA had positive earnings in 4 of the past 5 years.
OPRA had a positive operating cash flow in each of the past 5 years.
OPRA Yearly Net Income VS EBIT VS OCF VS FCFOPRA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

The Return On Assets of OPRA (7.53%) is better than 81.07% of its industry peers.
The Return On Equity of OPRA (8.43%) is better than 73.21% of its industry peers.
With an excellent Return On Invested Capital value of 8.38%, OPRA belongs to the best of the industry, outperforming 80.71% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for OPRA is significantly below the industry average of 11.76%.
The last Return On Invested Capital (8.38%) for OPRA is above the 3 year average (6.40%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.53%
ROE 8.43%
ROIC 8.38%
ROA(3y)8.12%
ROA(5y)7.3%
ROE(3y)8.98%
ROE(5y)7.94%
ROIC(3y)6.4%
ROIC(5y)N/A
OPRA Yearly ROA, ROE, ROICOPRA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 14.51%, OPRA is in the better half of the industry, outperforming 78.93% of the companies in the same industry.
In the last couple of years the Profit Margin of OPRA has declined.
With an excellent Operating Margin value of 16.45%, OPRA belongs to the best of the industry, outperforming 82.50% of the companies in the same industry.
With a Gross Margin value of 67.16%, OPRA perfoms like the industry average, outperforming 47.14% of the companies in the same industry.
OPRA's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 16.45%
PM (TTM) 14.51%
GM 67.16%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y-12.55%
GM growth 3Y-8.45%
GM growth 5Y-5.94%
OPRA Yearly Profit, Operating, Gross MarginsOPRA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80 100

8

2. Health

2.1 Basic Checks

OPRA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
OPRA has more shares outstanding than it did 1 year ago.
OPRA has less shares outstanding than it did 5 years ago.
The debt/assets ratio for OPRA has been reduced compared to a year ago.
OPRA Yearly Shares OutstandingOPRA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
OPRA Yearly Total Debt VS Total AssetsOPRA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 10.88 indicates that OPRA is not in any danger for bankruptcy at the moment.
OPRA has a better Altman-Z score (10.88) than 87.14% of its industry peers.
OPRA has a debt to FCF ratio of 0.09. This is a very positive value and a sign of high solvency as it would only need 0.09 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.09, OPRA belongs to the best of the industry, outperforming 81.43% of the companies in the same industry.
OPRA has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
OPRA has a better Debt to Equity ratio (0.01) than 66.79% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.09
Altman-Z 10.88
ROIC/WACC0.97
WACC8.66%
OPRA Yearly LT Debt VS Equity VS FCFOPRA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

OPRA has a Current Ratio of 2.43. This indicates that OPRA is financially healthy and has no problem in meeting its short term obligations.
OPRA has a Current ratio of 2.43. This is in the better half of the industry: OPRA outperforms 70.36% of its industry peers.
A Quick Ratio of 2.43 indicates that OPRA has no problem at all paying its short term obligations.
OPRA's Quick ratio of 2.43 is fine compared to the rest of the industry. OPRA outperforms 70.71% of its industry peers.
Industry RankSector Rank
Current Ratio 2.43
Quick Ratio 2.43
OPRA Yearly Current Assets VS Current LiabilitesOPRA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

7

3. Growth

3.1 Past

The earnings per share for OPRA have decreased strongly by -47.55% in the last year.
Measured over the past years, OPRA shows a very strong growth in Earnings Per Share. The EPS has been growing by 29.22% on average per year.
The Revenue has grown by 29.39% in the past year. This is a very strong growth!
OPRA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 22.22% yearly.
EPS 1Y (TTM)-47.55%
EPS 3Y189.45%
EPS 5Y29.22%
EPS Q2Q%8.33%
Revenue 1Y (TTM)29.39%
Revenue growth 3Y24.3%
Revenue growth 5Y22.22%
Sales Q2Q%30.28%

3.2 Future

OPRA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.17% yearly.
Based on estimates for the next years, OPRA will show a quite strong growth in Revenue. The Revenue will grow by 14.66% on average per year.
EPS Next Y16.72%
EPS Next 2Y18.61%
EPS Next 3Y20.67%
EPS Next 5Y17.17%
Revenue Next Year25.94%
Revenue Next 2Y20.2%
Revenue Next 3Y18.17%
Revenue Next 5Y14.66%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
OPRA Yearly Revenue VS EstimatesOPRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M 1B
OPRA Yearly EPS VS EstimatesOPRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0.5 1 1.5 2 2.5

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 18.34, the valuation of OPRA can be described as rather expensive.
Based on the Price/Earnings ratio, OPRA is valued cheaper than 80.36% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.41. OPRA is valued slightly cheaper when compared to this.
Based on the Price/Forward Earnings ratio of 14.38, the valuation of OPRA can be described as correct.
Based on the Price/Forward Earnings ratio, OPRA is valued cheaply inside the industry as 86.43% of the companies are valued more expensively.
OPRA is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.88, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 18.34
Fwd PE 14.38
OPRA Price Earnings VS Forward Price EarningsOPRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, OPRA is valued cheaply inside the industry as 85.71% of the companies are valued more expensively.
86.43% of the companies in the same industry are more expensive than OPRA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 17.09
EV/EBITDA 14.81
OPRA Per share dataOPRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
OPRA has a very decent profitability rating, which may justify a higher PE ratio.
OPRA's earnings are expected to grow with 20.67% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.1
PEG (5Y)0.63
EPS Next 2Y18.61%
EPS Next 3Y20.67%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.02%, OPRA is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 40.27, OPRA pays a better dividend. On top of this OPRA pays more dividend than 98.93% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, OPRA pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.02%

5.2 History

OPRA has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
OPRA Yearly Dividends per shareOPRA Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

OPRA pays out 78.12% of its income as dividend. This is not a sustainable payout ratio.
DP78.12%
EPS Next 2Y18.61%
EPS Next 3Y20.67%
OPRA Yearly Income VS Free CF VS DividendOPRA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M
OPRA Dividend Payout.OPRA Dividend Payout, showing the Payout Ratio.OPRA Dividend Payout.PayoutRetained Earnings

OPERA LTD-ADR

NASDAQ:OPRA (9/18/2025, 6:59:53 PM)

After market: 19.74 +0.12 (+0.61%)

19.62

+0.21 (+1.08%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-19 2025-08-19/bmo
Earnings (Next)10-27 2025-10-27/bmo
Inst Owners16.32%
Inst Owner Change-0.5%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.76B
Analysts83.08
Price Target26.01 (32.57%)
Short Float %6.28%
Short Ratio3.52
Dividend
Industry RankSector Rank
Dividend Yield 4.02%
Yearly Dividend0.43
Dividend Growth(5Y)N/A
DP78.12%
Div Incr Years0
Div Non Decr Years0
Ex-Date07-08 2025-07-08 (0.4)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.41%
Min EPS beat(2)-1.96%
Max EPS beat(2)8.78%
EPS beat(4)2
Avg EPS beat(4)1.28%
Min EPS beat(4)-3.68%
Max EPS beat(4)8.78%
EPS beat(8)5
Avg EPS beat(8)62.49%
EPS beat(12)7
Avg EPS beat(12)47.36%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.79%
Min Revenue beat(2)1.07%
Max Revenue beat(2)6.51%
Revenue beat(4)4
Avg Revenue beat(4)2.9%
Min Revenue beat(4)0.3%
Max Revenue beat(4)6.51%
Revenue beat(8)5
Avg Revenue beat(8)1.27%
Revenue beat(12)9
Avg Revenue beat(12)1.56%
Revenue beat(16)13
Avg Revenue beat(16)2.05%
PT rev (1m)-1.65%
PT rev (3m)-1.65%
EPS NQ rev (1m)15.96%
EPS NQ rev (3m)15.29%
EPS NY rev (1m)-5.77%
EPS NY rev (3m)-3.69%
Revenue NQ rev (1m)4.12%
Revenue NQ rev (3m)4.12%
Revenue NY rev (1m)3.27%
Revenue NY rev (3m)3.27%
Valuation
Industry RankSector Rank
PE 18.34
Fwd PE 14.38
P/S 3.16
P/FCF 17.09
P/OCF 16.63
P/B 1.84
P/tB 4.11
EV/EBITDA 14.81
EPS(TTM)1.07
EY5.45%
EPS(NY)1.36
Fwd EY6.95%
FCF(TTM)1.15
FCFY5.85%
OCF(TTM)1.18
OCFY6.01%
SpS6.21
BVpS10.68
TBVpS4.77
PEG (NY)1.1
PEG (5Y)0.63
Profitability
Industry RankSector Rank
ROA 7.53%
ROE 8.43%
ROCE 9.43%
ROIC 8.38%
ROICexc 9.73%
ROICexgc 26.48%
OM 16.45%
PM (TTM) 14.51%
GM 67.16%
FCFM 18.5%
ROA(3y)8.12%
ROA(5y)7.3%
ROE(3y)8.98%
ROE(5y)7.94%
ROIC(3y)6.4%
ROIC(5y)N/A
ROICexc(3y)7.3%
ROICexc(5y)N/A
ROICexgc(3y)20.62%
ROICexgc(5y)N/A
ROCE(3y)7.2%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y-12.55%
GM growth 3Y-8.45%
GM growth 5Y-5.94%
F-Score5
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.09
Debt/EBITDA 0.05
Cap/Depr 16.3%
Cap/Sales 0.52%
Interest Coverage 161.16
Cash Conversion 96.93%
Profit Quality 127.49%
Current Ratio 2.43
Quick Ratio 2.43
Altman-Z 10.88
F-Score5
WACC8.66%
ROIC/WACC0.97
Cap/Depr(3y)62.94%
Cap/Depr(5y)43.53%
Cap/Sales(3y)2.11%
Cap/Sales(5y)1.89%
Profit Quality(3y)170.05%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-47.55%
EPS 3Y189.45%
EPS 5Y29.22%
EPS Q2Q%8.33%
EPS Next Y16.72%
EPS Next 2Y18.61%
EPS Next 3Y20.67%
EPS Next 5Y17.17%
Revenue 1Y (TTM)29.39%
Revenue growth 3Y24.3%
Revenue growth 5Y22.22%
Sales Q2Q%30.28%
Revenue Next Year25.94%
Revenue Next 2Y20.2%
Revenue Next 3Y18.17%
Revenue Next 5Y14.66%
EBIT growth 1Y15.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year55.93%
EBIT Next 3Y29.74%
EBIT Next 5Y21.17%
FCF growth 1Y25.75%
FCF growth 3Y47.38%
FCF growth 5YN/A
OCF growth 1Y27.54%
OCF growth 3Y58.11%
OCF growth 5YN/A